Congenica: Tom Barber
Congenica, a UK-based firm specializing in clinical decision support for genomic data, has appointed Tom Barber as CSO. Barber most recently served as CSO at LifeOmic. Prior to that he established next-generation sequencing at Eli Lilly to identify preclinical and clinical models for personalized medicine. He has also previously worked at Beckman Coulter, where he was involved in automated NGS sample prep and clinical NGS initiatives.
Sema4: Katherine Stueland, Eric Schadt
As part of its acquisition of GeneDx from Opko Health, Sema4 has named former GeneDx President and CEO Katherine Stueland its new CEO. She replaces Sema4 Founder Eric Schadt, who now will serve as president and chief R&D officer. This represents a change from previously announced plans for Stueland and Schadt to share the CEO role. Stueland had joined GeneDx last year after serving as chief commercial officer of Invitae.
Centogene: Volkmar Weckesser
Volkmar Weckesser has resigned as chief information officer of Centogene. He will remain a consultant for the company until its upcoming annual general meeting. Weckesser joined Centogene in 2016.
For additional recent items on executive appointments, promotions, and departures in omics and molecular diagnostics, please see the People in the News page on our website.